Skip to main content
. 2022 Nov 7;14(21):5465. doi: 10.3390/cancers14215465

Table 5.

Overall survival and progression-free survival in the univariate analysis and consecutive multivariate Cox proportional hazard regression.

Univariate Analysis OS Multivariate Analysis OS
Prognostic Factor p-Value p-Value HR (95% CI)
GPS <0.0001 <0.0001 3.459 (1.263–6.322)
PI * 0.02 0.690 2.344 (1.513–8.436)
PNI ** 0.005 0.409 0.851(0.535–4.331)
ECOG <0.0001 0.042 1.667 (0.828–4.189)
CCI > 3 0.006 0.530 0.715 (0.299–6.299)
UICC IV <0.0001 0.001 1.155 (0.870–1.399)
NEC (G3) <0.0001 0.004 1.271 (0.930–1.661)
Univariate Analysis PFS Multivariate Analysis PFS
p-Value p-Value HR (95% CI)
GPS <0.0001 0.002 2.119 (0.944–4.265)
PI * 0.02 0.518 2.775 (1.984–4.372)
PNI ** 0.065 0.644 1.384 (1.015–1.855)
ECOG 0.08 0.453 2.248 (1.433–3.556)
CCI > 3 0.004 0.092 4.210 (1.936–6.501)
UICC IV <0.0001 0.067 1.582 (1.214–2.737)
NEC (G3) 0.0004 0.081 1.322 (0.862–2.453)

CCI, Charlson Comorbidity Index; GPS, Glasgow Prognostic Score; OS, overall survival; PFS, progression-free survival; PI, prognostic index; PNI, prognostic nutritional Index; UICC, Union InterNational Contre le Cancer. * CRP > 10 mg/dL, white blood cell count > 11,000/μL, ** >50.